VG Life Sciences Inc. is a drug discovery and development company focused on two core technologies: Targeted Peptide Technology (TPT), aimed at treating autoimmune diseases using peptide compound VG1177, and Metabolic Disruption Technology (MDT), used in combination with drugs like hydroxychloroquine and sorafenib (Nexavar) to treat drug-resistant solid tumors. The company holds exclusive licenses to technology developed by Dr. M. Karen Newell Rogers and operates subsidiaries VG Energy, Inc. and MetaCytoLytics, Inc.
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2015-04-15 | 2014-12-31 | 0001019687-15-001463 | EDGAR | 95K words |
| 2001-08-28 | 2001-05-31 | 0001052918-01-500082 | EDGAR | — |
| 2000-08-29 | 2000-05-31 | 0001091326-00-000015 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2015-11-19 | 2015-09-30 | 0001019687-15-004252 | EDGAR | 26K words |
| 2015-08-19 | 2015-06-30 | 0001019687-15-003202 | EDGAR | — |
| 2015-05-20 | 2015-03-31 | 0001019687-15-002045 | EDGAR | — |
| 2014-11-13 | 2014-09-30 | 0001019687-14-004238 | EDGAR | — |
| 2001-04-13 | 2001-02-28 | 0001052918-01-000074 | EDGAR | — |
| 2001-01-16 | 2000-11-30 | 0001052918-01-000016 | EDGAR | — |
| 2000-10-13 | 2000-08-31 | 0001091326-00-000017 | EDGAR | — |
| 2000-04-10 | 2000-02-29 | 0001091326-00-000004 | EDGAR | — |
| 2000-01-26 | 1999-11-30 | 0000897101-00-000051 | EDGAR | — |
| 1999-10-28 | 1999-08-31 | 0000897101-99-001009 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2016-03-30 | 0001019687-16-005617 | EDGAR | 1K words |
| 2015-05-21 | 0001019687-15-002082 | EDGAR | — |
| 2015-05-18 | 0001019687-15-002009 | EDGAR | — |
| 2015-01-22 | 0001019687-15-000296 | EDGAR | — |
| 2014-09-11 | 0001019687-14-003552 | EDGAR | — |
| 2009-02-17 | 0001214659-09-000300 | EDGAR | — |
| 2008-11-18 | 0001214659-08-002537 | EDGAR | — |
| 2008-09-02 | 0001214659-08-002004 | EDGAR | — |
| 2008-08-08 | 0001214659-08-001787 | EDGAR | — |
| 2008-07-08 | 0001214659-08-001555 | EDGAR | — |
58 total filings indexed. 35 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001091326 |
| Ticker | VGLS |
| Exchange | OTC |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/VGLS (~200 tokens, structured JSON with cryptographic provenance)